![Alan Hulme](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Hulme
Direttore/Membro del Consiglio presso Oncopeptides Incentive AB
Patrimonio netto: 139 294 $ in data 31/05/2024
Posizioni attive di Alan Hulme
Società | Posizione | Inizio | Fine |
---|---|---|---|
Oncopeptides Incentive AB | Direttore/Membro del Consiglio | - | - |
Techgen Corporate Development Ltd. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Alan Hulme
Precedenti posizioni note di Alan Hulme
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONCOPEPTIDES AB | Presidente | 24/04/2010 | 17/05/2018 |
Independent Dir/Board Member | 01/04/2010 | 17/05/2018 | |
Quiatech AB
![]() Quiatech AB Pharmaceuticals: MajorHealth Technology Quiatech AB develops and manufactures drugs. It is a research based company that develops enabling technologies for genetic analysis, molecular diagnostics, and gene-based therapeutics in the expanding market of DNA technologies that offer significant improvements in the quality of DNA microarray and other DNA oligonucleotide data. It has also developed a new modified RNA chemistry (Qt RNA Technology) utilizing a novel 2 protecting group on the RNA amidites, this development greatly improves the synthesis conditions, producing fully functional RNA at high yields. It is headquartered in Uppsala, Sweden. | Direttore/Membro del Consiglio | - | 30/08/2007 |
Techgen International Ltd.
![]() Techgen International Ltd. Miscellaneous Commercial ServicesCommercial Services Techgen International Ltd. provides financial advisory services. The private company is based in London, UK. | Presidente | - | - |
OLIGOvation AB
![]() OLIGOvation AB Miscellaneous Commercial ServicesCommercial Services OLIGOvation AB develops enabling technologies for genetic analysis, molecular diagnostics and gene-based therapeutics. It offers services in the market of DNA technologies that offer improvements in the quality of DNA microarray and other DNA oligonucleotide data. The company was founded in February, 2000 and is headquartered in Uppsala, Sweden. | Direttore/Membro del Consiglio | - | - |
Mesophotonics Ltd.
![]() Mesophotonics Ltd. Computer CommunicationsElectronic Technology Mesophotonics Ltd. develops photonic crystal devices and circuits. Its devices allows light to be bent, routed and processed at sub-millimeter scale. It offers multiple optical functions and systems to be implemented on a single silicon chip for production of integrated optical devices. The company was founded by Caterina Netti, Majd Zoorob, Simon Cox, James Wilkinson, Greg Parker, Martin Charlton and Jeremy Baumberg in July 2001 and is headquartered in Southampton, UK. | Direttore/Membro del Consiglio | - | - |
AFFYMETRIX, INC. | Corporate Officer/Principal | - | - |
IDEXX LABORATORIES, INC. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Svezia | 5 |
Regno Unito | 4 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 5 |
Corporate Officer/Principal | 2 |
Chairman | 2 |
Settori
Health Technology | 5 |
Commercial Services | 3 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
IDEXX LABORATORIES, INC. | Health Technology |
ONCOPEPTIDES AB | Health Technology |
Aziende private | 7 |
---|---|
Affymetrix, Inc.
![]() Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Quiatech AB
![]() Quiatech AB Pharmaceuticals: MajorHealth Technology Quiatech AB develops and manufactures drugs. It is a research based company that develops enabling technologies for genetic analysis, molecular diagnostics, and gene-based therapeutics in the expanding market of DNA technologies that offer significant improvements in the quality of DNA microarray and other DNA oligonucleotide data. It has also developed a new modified RNA chemistry (Qt RNA Technology) utilizing a novel 2 protecting group on the RNA amidites, this development greatly improves the synthesis conditions, producing fully functional RNA at high yields. It is headquartered in Uppsala, Sweden. | Health Technology |
Mesophotonics Ltd.
![]() Mesophotonics Ltd. Computer CommunicationsElectronic Technology Mesophotonics Ltd. develops photonic crystal devices and circuits. Its devices allows light to be bent, routed and processed at sub-millimeter scale. It offers multiple optical functions and systems to be implemented on a single silicon chip for production of integrated optical devices. The company was founded by Caterina Netti, Majd Zoorob, Simon Cox, James Wilkinson, Greg Parker, Martin Charlton and Jeremy Baumberg in July 2001 and is headquartered in Southampton, UK. | Electronic Technology |
OLIGOvation AB
![]() OLIGOvation AB Miscellaneous Commercial ServicesCommercial Services OLIGOvation AB develops enabling technologies for genetic analysis, molecular diagnostics and gene-based therapeutics. It offers services in the market of DNA technologies that offer improvements in the quality of DNA microarray and other DNA oligonucleotide data. The company was founded in February, 2000 and is headquartered in Uppsala, Sweden. | Commercial Services |
Techgen International Ltd.
![]() Techgen International Ltd. Miscellaneous Commercial ServicesCommercial Services Techgen International Ltd. provides financial advisory services. The private company is based in London, UK. | Commercial Services |
Oncopeptides Incentive AB | |
Techgen Corporate Development Ltd. |
- Borsa valori
- Insiders
- Alan Hulme
- Esperienza